pancreatitis from tirzepatide Can (Zepbound) be prescribed to a patient with a prior history of pancreatitis? Pancreatic Safety of Tirzepatide and

Its important not to navigate this time alone

Current as of December 2025

Previously, administration of GC via oral, rectal, IV and IM routes was prohibited in-competition due to clear evidence of systemic effects however this ban has now been extended to include any in-competition injection of GC (e.g., intravenous, intramuscular, periarticular, intra-articular, peritendinous, intratendinous, epidural, intrathecal, intrabursal, intralesional (e.g., intrakeloid), intradermal, and subcutaneous)

Steinert, R

DOI: 10.1016/j.clim.2024.110173

The main consideration is the indirect effect of weight loss on warfarin dosing, as your weight decreases, your warfarin dose may need reducing to keep your INR in range